Synektik reports PLN 493 million in orders while Synektik stock trades at EUR 78.65

Published on 10/15/2026 at 13:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Orders reached PLN 493 million in fiscal year 2025/2026, up from PLN 391 million. Synektik stock costs EUR 78.65 on October 15, 2026.

Order cycle and reporting dates

Synektik estimated PLN 493 million in secured orders for fiscal year 2025/2026 on October 14, 2026, versus PLN 391 million a year earlier.
Backlog stood at PLN 43.3 million on September 30, 2026, compared with PLN 75.9 million one year earlier.
Synektik stock was trading at EUR 78.65 at 1:18 p.m. CEST at Lang & Schwarz on October 15, 2026.

Synektik, PLSNKTK00019, Illustration mit AI erstellt.

Synektik (PLSNKTK00019) secured orders worth PLN 493 million in fiscal year 2025/2026, up from PLN 391 million a year earlier, according to PAP on October 14, 2026. The annual increase contrasts with a weaker final quarter and puts the order pipeline ahead of the next reporting date.

Annual orders set a high bar

The company estimated secured medical-equipment orders at PLN 70 million in the fourth quarter of fiscal year 2025/2026, compared with PLN 145 million in the prior-year period. The annual total nevertheless rose by PLN 102 million, or 26.09 percent, from PLN 391 million to PLN 493 million.

The same report put active offerings at PLN 200.1 million on September 30, 2026, versus PLN 198.7 million one year earlier. That PLN 1.4 million increase leaves the sales opportunity pool broadly stable even as completed orders were uneven across the year.

What does the order cycle mean for backlog?

Backlog fell to PLN 43.3 million on September 30, 2026, from PLN 75.9 million a year earlier, according to PAP. The PLN 32.6 million reduction means delivery timing and conversion of active offers will matter more than the annual order headline when the next results arrive.

Three dated milestones for investors

On October 8, 2026, Synektik signed a PLN 15.01 million contract for consumables for the da Vinci surgical system, as reported by Stockd. On October 14, 2026, the company disclosed the PLN 493 million annual order estimate. On October 15, 2026, it published its reporting calendar, including the next quarterly report on November 18, 2026, according to Puls Biznesu.

Next reports bring the next test

Synektik is scheduled to publish its consolidated quarterly report for the fourth fiscal quarter of 2025 on November 18, 2026. Its annual reports for fiscal year 2025 are scheduled for December 22, 2026, according to Puls Biznesu. Those dates should clarify how the large annual order intake translates into revenue and earnings.

Stock price and trading view

Synektik was trading at EUR 78.65 at Lang & Schwarz on October 15, 2026 at 1:18 p.m. CEST. On its primary exchange, GPW, the stock is identified as SNT.WA in PLN, while an October 2026 market reference put its market capitalization at PLN 2.53 billion.

The company operates in medical equipment, information technology solutions and radiopharmaceutical products for surgery, diagnostic imaging and nuclear medicine. Its next disclosed quarterly reporting date is November 18, 2026.

The further course of trading is shown by the continuously updated real-time quote of Synektik stock.